CUE
Cue Biopharma, Inc.
$13.26-4.67 (-26.05%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Cue Biopharma, Inc. (CUE) is a publicly traded company with 3 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 20 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | 2026-04-09 | Sandercock Colin | SVP | Award | 200,000 | $0.29 | $58,000 | N/A | N/A |
| 2026-04-10 | 2026-04-09 | Warren Lucinda | CBO | Award | 250,000 | $0.29 | $72,500 | N/A | N/A |
| 2026-04-10 | 2026-04-09 | Baker Daniel G. | CDO | Award | 100,000 | $0.29 | $29,000 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Garzone Pamela | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Sarraf Pasha | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Kiener Peter A | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Broadfoot Jill Marie | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Verheyen Patrick | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Morich Frank | Director | Award | 24,400 | $0.00 | $0 | N/A | N/A |
| 2026-01-02 | 2025-12-30 | Sarraf Pasha | Director | Purchase | 77,148 | $0.30 | $23,144 | +23.3% | +20.0% |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.